相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
Khun Visith Keu et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Toxicities of chimeric antigen receptor T cells: recognition and management
Jennifer N. Brudno et al.
BLOOD (2016)
Longitudinal PET imaging demonstrates biphasic CAR T cell responses in survivors
Yogindra Vedvyas et al.
JCI INSIGHT (2016)
Multiplex Genome-Edited T-cell Manufacturing Platform for Off-the-Shelf Adoptive T-cell Immunotherapies
Laurent Poirot et al.
CANCER RESEARCH (2015)
Affinity-Tuned ErbB2 or EGFR Chimeric Antigen Receptor T Cells Exhibit an Increased Therapeutic Index against Tumors in Mice
Xiaojun Liu et al.
CANCER RESEARCH (2015)
Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity
Hillary G. Caruso et al.
CANCER RESEARCH (2015)
Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens
Michael Hebeisen et al.
FRONTIERS IN IMMUNOLOGY (2015)
Target Antigen Density Governs the Efficacy of Anti-CD20-CD28-CD3 ζ Chimeric Antigen Receptor-Modified Effector CD8+ T Cells
Keisuke Watanabe et al.
JOURNAL OF IMMUNOLOGY (2015)
Side-by-Side Comparison of Commonly Used Biomolecules That Differ in Size and Affinity on Tumor Uptake and Internalization
Jeerapond Leelawattanachai et al.
PLOS ONE (2015)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
Preclinical Evaluation of a High-Affinity 18F-Trifluoroborate Octreotate Derivative for Somatostatin Receptor Imaging
Zhibo Liu et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
ICAM-1 as a molecular target for triple negative breast cancer
Peng Guo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tumor suppression via paclitaxel-loaded drug carriers that target inflammation marker upregulated in tumor vasculature and macrophages
Spencer Park et al.
BIOMATERIALS (2013)
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Michael Hudecek et al.
CLINICAL CANCER RESEARCH (2013)
Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents
S. Kang et al.
GENE THERAPY (2013)
Intercellular adhesion molecule-1 (ICAM-1) expression correlates with oral cancer progression and induces macrophage/cancer cell adhesion
Yu Usami et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Reassessing target antigens for adoptive T-cell therapy
Christian S. Hinrichs et al.
NATURE BIOTECHNOLOGY (2013)
Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia
Stephan A. Grupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy
Shi Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
Renier J. Brentjens et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Visualizing and Quantifying Acute Inflammation Using ICAM-1 Specific Nanoparticles and MRI Quantitative Susceptibility Mapping
Richard Wong et al.
ANNALS OF BIOMEDICAL ENGINEERING (2012)
The serial engagement model 17 years after: from TCR triggering to immunotherapy
Salvatore Valitutti
FRONTIERS IN IMMUNOLOGY (2012)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19
James N. Kochenderfer et al.
BLOOD (2010)
Evidence for a TCR Affinity Threshold Delimiting Maximal CD8 T Cell Function
Daphne A. Schmid et al.
JOURNAL OF IMMUNOLOGY (2010)
A Novel Facile Method of Labeling Octreotide with 18F-Fluorine
Peter Laverman et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
Richard A. Morgan et al.
MOLECULAR THERAPY (2010)
Positron Emission Tomography-Computed Tomography Standardized Uptake Values in Clinical Practice and Assessing Response to Therapy
Paul E. Kinahan et al.
SEMINARS IN ULTRASOUND CT AND MRI (2010)
Attenuated T Cell Responses to a High-Potency Ligand In Vivo
Emily Corse et al.
PLOS BIOLOGY (2010)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
A Novel Method of 18F Radiolabeling for PET
William J. McBride et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Noninvasive detection of therapeutic cytolytic T cells with F-18-FHBG PET in a patient with glioma
Shahriar S. Yaghoubi et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions
Paul F. Robbins et al.
JOURNAL OF IMMUNOLOGY (2008)
CD8+ T cell activation is governed by TCR-Peptide/MHC affinity, not dissociation rate
Shaomin Tian et al.
JOURNAL OF IMMUNOLOGY (2007)
ICAM-1 expression determines malignant potential of cancer
Christina L. Roland et al.
SURGERY (2007)
In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor
Alexandre Boissonnas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Directed evolution to probe protein allostery and integrin I domains of 200,000-fold higher affinity
M Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The onset of CD8+-T-cell contraction is influenced by the peak of Listeria monocytogenes infection and antigen display
BB Porter et al.
INFECTION AND IMMUNITY (2006)
T cell activation by antibody-like immunoreceptors: Increase in affinity of the single-chain fragment domain above threshold does not increase T cell activation against antigen-positive target cells but decreases selectivity
M Chmielewski et al.
JOURNAL OF IMMUNOLOGY (2004)
Integrin avidity regulation: are changes in affinity and conformation underemphasized?
CV Carman et al.
CURRENT OPINION IN CELL BIOLOGY (2003)
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCR zeta/CD28 receptor
J Maher et al.
NATURE BIOTECHNOLOGY (2002)
Reversibly locking a protein fold in an active conformation with a disulfide bond:: Integrin αL I domains with high affinity and antagonist activity in vivo
M Shimaoka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Efficient cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex
AM Kalergis et al.
NATURE IMMUNOLOGY (2001)
分享论文
